Skip to main content

Table 1 HIV-1 genotype drug resistance profile to PRI, RTI and INIs of chronically infected HIV-1 subtype C patients

From: Lack of integrase inhibitors associated resistance mutations among HIV-1C isolates

ID

Age/sex

RNA

CD4 count

Resistance to PRIs

Resistance to RTIs

Resistance to INIs

5572

28/M

5.18

20

Minor R (V11FV)

S

S

5492

30/F

5.38

27

S

S

S

5493

23/F

5.28

33

S

S

S

5790

45/M

4.18

37

S

S

S

5531

24/F

6.17

38

S

S

S

5655

29/F

3.75

48

S

S

S

5551

28/M

4.66

59

S

S

S

5642

25/F

4.01

60

S

S

S

5775

45/F

3.85

61

S

S

S

5595

25/M

4.32

66

S

S

S

5592

55/M

5.82

75

S

S

S

5717

28/F

4.21

75

S

S

S

5525

30/F

4.79

80

S

S

S

5648

35/F

5.04

85

S

S

S

5591

33/M

4.37

85

S

S

S

5582

32/M

5.43

89

S

S

S

5568

36/M

3.90

92

S

S

S

5499

35/M

5.91

97

S

S

S

5604

27/M

4.64

97

S

S

S

5517

25/F

3.83

112

S

S

S

5627

30/F

3.08

115

S

S

S

5732

36/F

5.14

118

S

S

S

5479

35/F

5.44

124

S

R–NNRTIs (E138G)

S

5546

38/F

4.33

125

S

S

S

5841

58/M

4.47

129

S

S

S

5733

32/F

4.78

146

S

S

S

5713

38/F

3.86

182

S

S

S

5681

28/M

4.38

191

S

S

S

5550

43/M

4.66

209

S

S

S

5786

27/F

3.88

211

S

S

S

5837

28/F

3.76

212

S

S

S

5768

44/M

5.91

219

S

S

S

5712

39/M

4.82

224

S

R–NNRTIs (G190A)

S

5669

40/F

3.57

227

Minor R (L10I)

S

S

5585

47/F

4.60

227

S

S

S

5596

27/F

4.8

238

S

S

S

5511

20/F

4.54

262

S

S

S

5524

42/M

3.90

269

S

S

S

5485

40/M

4.50

277

S

S

S

5690

30/M

3.30

312

S

S

S

5530

24/F

3.81

336

S

S

S

5582

34/M

5.43

366

S

S

S

5630

28/M

4.17

401

S

S

S

5511

24/F

4.54

421

S

S

S

5496

40/M

3.88

751

S

R–NRTIs (L210 W)

S

  1. M Male, F Female, HIV RNA in log10 copies/ml; CD4+ T cell count (cells/mm3); PRI protease inhibitors, RTI reverse transcriptase inhibitors, INI integrase inhibitors, S susceptible, R resistance